No Data
No Data
Express News | Kangenbei's innovative traditional Chinese medicine yellow holly flower flavonoid oral patch received a reward of 10 million yuan from the government
Conn Bay (600572.SH)'s net profit of 216 million yuan in the first quarter decreased by 23.98% year-on-year
On April 26, Ge Longhui (600572.SH) released its report for the first quarter of 2024. Operating revenue for the reporting period was 1,824 million yuan, a year-on-year decrease of 14.38%; net profit attributable to shareholders of listed companies was 216 million yuan, a year-on-year decrease of 23.98%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 201 million yuan, a year-on-year decrease of 23.57%; and basic earnings per share were 0.084 yuan.
Guoyuan Securities released a research report on April 24 stating that it gave Kangenbei (600572.SH) a purchase rating. The main reasons for the rating include: 1) Performance growth is in line with expectations, and the overall business trend continues t
Guoyuan Securities released a research report on April 24 stating that it gave Kangenbei (600572.SH) a purchase rating. The main reasons for the rating include: 1) Performance growth is in line with expectations, and the overall business trend continues to improve; 2) Innovative R&D continues to accelerate, and future growth momentum is sufficient. (Mainichi Keizai Shimbun)
SDIC Securities released a research report on April 24 stating that it gave Kangenbei (600572.SH) a purchase rating and the target price was 7.00 yuan. The main reasons for the rating include: 1) the performance is in line with expectations, and the busin
SDIC Securities released a research report on April 24 stating that it gave Kangenbei (600572.SH) a purchase rating and the target price was 7.00 yuan. The main reasons for the rating include: 1) the performance is in line with expectations, and the business classification criteria are adjusted according to the development strategy; 2) adhering to the “big variety, big brand” strategy, the core product, the Changyan Ning series, has grown brilliantly. (Mainichi Keizai Shimbun)
Conn Bay (600572) 2023 Annual Report Review: Main business focuses on accelerating steady growth in performance
Incident: The company released the 2023 annual report, achieving operating income of 6.733 billion yuan, a year-on-year increase of 12.20%; net profit to mother of 592 million yuan, an increase of 65.19% over the previous year; net profit after deduction of 5.54 billion yuan
Kangenbei (600572): Steady growth in performance, accelerated development of traditional Chinese medicine health business
Incident: The company released its 2023 annual report. The full year of 2023 achieved revenue of 6.733 billion yuan (yoy +12.21%), net profit of 592 million yuan (yoy +65.19%), deducted from non-return to mother
No Data